Medical device CRO Factory brings Boston Biomedical into its fold

Handshake business deal executives
Factory-CRO Group, a medical device and in vitro diagnostics-focused CRO based in the Netherlands, has merged with U.S.-based Boston Biomedical Associates. (Pixabay)

Factory-CRO Group, a medical device and in vitro diagnostics-focused CRO based in the Netherlands, has merged with U.S.-based Boston Biomedical Associates.

Financial terms of the deal weren’t announced.

With the addition of Boston Biomedical, Factory-CRO Group now boasts expanded operations in the U.S., as well as sites in Australia, New Zealand and Europe. Factory-CRO Group said its goal is to become the leading global CRO focused on medical devices and medical technology. 

INDUSTRY RESEARCH

Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.

“This merger allows us to provide our specialized expertise and a continued commitment to the highest level of customized service to a larger audience,” Dirk Meijer, M.D., Ph.D., the company’s chief executive, said in a statement. “We operate from our own offices located within each region housed with employees that have refined expertise to meet our unique client needs.”

A little over a year ago, Factory-CRO Group acquired Milestone Research Organization. Factory-CRO Group offers medical device companies services in data management, consultancy regarding study design and budget and regulatory strategy, regulatory filings, clinical monitoring and reimbursement.